CZ ATC C09AA05 · updated 2 Nov 2026
Ramipril shortage in Czechia
Is there a Ramipril shortage in Czechia?
Yes. As of 2 Nov 2026, 8 Ramipril products are reported short in Czechia, the first since 8 Sep 2026. The company estimate for the return is 6 Nov 2026 (latest 19 Feb 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Ireland, Austria, Belgium, Sweden, New Zealand, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | PIRAMIL 1,25MG 1,25MG TBL NOB 30 I | Sandoz GmbH, Kundl | 8 Sep 2026 | 20 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | PIRAMIL 5MG 5MG TBL NOB 100 I | Sandoz GmbH, Kundl | 10 Sep 2026 | 6 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | PIRAMIL 1,25MG 1,25MG TBL NOB 100 I | Sandoz GmbH, Kundl | 18 Sep 2026 | 27 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | PIRAMIL 2,5MG 2,5MG TBL NOB 30 I | Sandoz GmbH, Kundl | 22 Sep 2026 | 19 Feb 2027 | Manufacturing problem Výrobní důvody |
| CZ | RAMIPRIL ACTAVIS 2,5MG 2,5MG TBL NOB 30 | Teva | 2 Oct 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | RAMIPRIL ACTAVIS 10MG 10MG TBL NOB 90 | Teva | 12 Oct 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | RAMIPRIL ACTAVIS 2,5MG 2,5MG TBL NOB 50 | Teva | 17 Oct 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | RAMIPRIL ACTAVIS 5MG 5MG TBL NOB 90 | Teva | 2 Nov 2026 | 31 Dec 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.